Impact of COVID-19 on cervical cancer screening: Challenges and opportunities to improving resilience and reduce disparities

The COVID-19 pandemic has a major impact on a wide range of health outcomes. Disruptions of elective health services related to cervical screening, management of abnormal screening test results, and treatment of precancers, may lead to increases in cervical cancer incidence and exacerbate existing h...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Preventive medicine 2021-10, Vol.151, p.106596-106596, Article 106596
Hauptverfasser: Wentzensen, Nicolas, Clarke, Megan A., Perkins, Rebecca B.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 106596
container_issue
container_start_page 106596
container_title Preventive medicine
container_volume 151
creator Wentzensen, Nicolas
Clarke, Megan A.
Perkins, Rebecca B.
description The COVID-19 pandemic has a major impact on a wide range of health outcomes. Disruptions of elective health services related to cervical screening, management of abnormal screening test results, and treatment of precancers, may lead to increases in cervical cancer incidence and exacerbate existing health disparities. Modeling studies suggest that a short delay of cervical screening in subjects with previously negative HPV results has minor effects on cancer outcomes, while delay of management and treatment can lead to larger increases in cervical cancer. Several approaches can mitigate the effects of disruption of cervical screening and management. HPV-based screening has higher accuracy compared to cytology, and a negative HPV result provides longer reassurance against cervical cancer; further, HPV testing can be conducted from self-collected specimens. Self-collection expands the reach of screening to underserved populations who currently do not participate in screening. Self-collection and can also provide alternative screening approaches during the pandemic because testing can be supported by telehealth and specimens collected in the home, substantially reducing patient-provider contact and risk of COVID-19 exposure, and also expanding the reach of catch-up services to address backlogs of screening tests that accumulated during the pandemic. Risk-based management allows prioritizing management of patients at highest risk of cervical cancer while extending screening intervals for those at lowest risk. The pandemic provides important lessons for how to make cervical screening more resilient to disruptions and how to reduce cervical cancer disparities that may be exacerbated due to disruptions of health services. •The pandemic increases disparities in cervical cancer prevention.•HPV self-sampling can extend the reach of cervical screening.•Screening and management visits should be prioritized by risk.•The pandemic provides an opportunity to make cervical screening more resilient.
doi_str_mv 10.1016/j.ypmed.2021.106596
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8241689</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0091743521001808</els_id><sourcerecordid>2548601298</sourcerecordid><originalsourceid>FETCH-LOGICAL-c525t-5aeca93f577d21838407c1376e3aa0ad42af6059c10f3f61ebb7aa56ff295e7d3</originalsourceid><addsrcrecordid>eNp9kU-LFDEQxYMo7rj6CQTJ0UuPSbqT7hYUZPw3sLAX9Rpqkspshu6kTboHFvzwZmfWRS-eUlR-9ap4j5CXnK054-rNYX07jWjXggleOkr26hFZcdarignFHpMVYz2v2qaWF-RZzgfGOFeseUou6kbwtuFyRX5txwnMTKOjm-sf248V72kM1GA6egMDNRBKTbNJiMGH_Vu6uYFhwLDHTCFYGqcppnkJfvalM0fqxynFY0FpwuwHj0XgRCa0SymtzxOkE_6cPHEwZHxx_16S758_fdt8ra6uv2w3H64qI4WcKwlooK-dbFsreFd3DWsNr1uFNQAD2whwisnecOZqpzjudi2AVM6JXmJr60vy_qw7LbvimMEwJxj0lPwI6VZH8Prfn-Bv9D4edScarrq-CLy-F0jx54J51qPPBocBAsYlayGbTjEu-q6g9Rk1Keac0D2s4Uzf5aYP-pSbvstNn3MrU6_-vvBh5k9QBXh3BrD4dPSYdDYna61PaGZto__vgt8LCK1F</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2548601298</pqid></control><display><type>article</type><title>Impact of COVID-19 on cervical cancer screening: Challenges and opportunities to improving resilience and reduce disparities</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Wentzensen, Nicolas ; Clarke, Megan A. ; Perkins, Rebecca B.</creator><creatorcontrib>Wentzensen, Nicolas ; Clarke, Megan A. ; Perkins, Rebecca B.</creatorcontrib><description>The COVID-19 pandemic has a major impact on a wide range of health outcomes. Disruptions of elective health services related to cervical screening, management of abnormal screening test results, and treatment of precancers, may lead to increases in cervical cancer incidence and exacerbate existing health disparities. Modeling studies suggest that a short delay of cervical screening in subjects with previously negative HPV results has minor effects on cancer outcomes, while delay of management and treatment can lead to larger increases in cervical cancer. Several approaches can mitigate the effects of disruption of cervical screening and management. HPV-based screening has higher accuracy compared to cytology, and a negative HPV result provides longer reassurance against cervical cancer; further, HPV testing can be conducted from self-collected specimens. Self-collection expands the reach of screening to underserved populations who currently do not participate in screening. Self-collection and can also provide alternative screening approaches during the pandemic because testing can be supported by telehealth and specimens collected in the home, substantially reducing patient-provider contact and risk of COVID-19 exposure, and also expanding the reach of catch-up services to address backlogs of screening tests that accumulated during the pandemic. Risk-based management allows prioritizing management of patients at highest risk of cervical cancer while extending screening intervals for those at lowest risk. The pandemic provides important lessons for how to make cervical screening more resilient to disruptions and how to reduce cervical cancer disparities that may be exacerbated due to disruptions of health services. •The pandemic increases disparities in cervical cancer prevention.•HPV self-sampling can extend the reach of cervical screening.•Screening and management visits should be prioritized by risk.•The pandemic provides an opportunity to make cervical screening more resilient.</description><identifier>ISSN: 0091-7435</identifier><identifier>ISSN: 1096-0260</identifier><identifier>EISSN: 1096-0260</identifier><identifier>DOI: 10.1016/j.ypmed.2021.106596</identifier><identifier>PMID: 34217415</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Cervical cancer ; Cervical precancer ; COVID-19 ; Early Detection of Cancer ; Female ; Health disparities ; HPV ; Humans ; Mass Screening ; Pandemic ; Pandemics ; Papillomaviridae ; Papillomavirus Infections - diagnosis ; Papillomavirus Infections - epidemiology ; SARS-CoV-2 ; Screening ; Uterine Cervical Neoplasms - diagnosis ; Uterine Cervical Neoplasms - epidemiology</subject><ispartof>Preventive medicine, 2021-10, Vol.151, p.106596-106596, Article 106596</ispartof><rights>2021</rights><rights>Copyright © 2021. Published by Elsevier Inc.</rights><rights>2021 Published by Elsevier Inc. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c525t-5aeca93f577d21838407c1376e3aa0ad42af6059c10f3f61ebb7aa56ff295e7d3</citedby><cites>FETCH-LOGICAL-c525t-5aeca93f577d21838407c1376e3aa0ad42af6059c10f3f61ebb7aa56ff295e7d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0091743521001808$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34217415$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wentzensen, Nicolas</creatorcontrib><creatorcontrib>Clarke, Megan A.</creatorcontrib><creatorcontrib>Perkins, Rebecca B.</creatorcontrib><title>Impact of COVID-19 on cervical cancer screening: Challenges and opportunities to improving resilience and reduce disparities</title><title>Preventive medicine</title><addtitle>Prev Med</addtitle><description>The COVID-19 pandemic has a major impact on a wide range of health outcomes. Disruptions of elective health services related to cervical screening, management of abnormal screening test results, and treatment of precancers, may lead to increases in cervical cancer incidence and exacerbate existing health disparities. Modeling studies suggest that a short delay of cervical screening in subjects with previously negative HPV results has minor effects on cancer outcomes, while delay of management and treatment can lead to larger increases in cervical cancer. Several approaches can mitigate the effects of disruption of cervical screening and management. HPV-based screening has higher accuracy compared to cytology, and a negative HPV result provides longer reassurance against cervical cancer; further, HPV testing can be conducted from self-collected specimens. Self-collection expands the reach of screening to underserved populations who currently do not participate in screening. Self-collection and can also provide alternative screening approaches during the pandemic because testing can be supported by telehealth and specimens collected in the home, substantially reducing patient-provider contact and risk of COVID-19 exposure, and also expanding the reach of catch-up services to address backlogs of screening tests that accumulated during the pandemic. Risk-based management allows prioritizing management of patients at highest risk of cervical cancer while extending screening intervals for those at lowest risk. The pandemic provides important lessons for how to make cervical screening more resilient to disruptions and how to reduce cervical cancer disparities that may be exacerbated due to disruptions of health services. •The pandemic increases disparities in cervical cancer prevention.•HPV self-sampling can extend the reach of cervical screening.•Screening and management visits should be prioritized by risk.•The pandemic provides an opportunity to make cervical screening more resilient.</description><subject>Cervical cancer</subject><subject>Cervical precancer</subject><subject>COVID-19</subject><subject>Early Detection of Cancer</subject><subject>Female</subject><subject>Health disparities</subject><subject>HPV</subject><subject>Humans</subject><subject>Mass Screening</subject><subject>Pandemic</subject><subject>Pandemics</subject><subject>Papillomaviridae</subject><subject>Papillomavirus Infections - diagnosis</subject><subject>Papillomavirus Infections - epidemiology</subject><subject>SARS-CoV-2</subject><subject>Screening</subject><subject>Uterine Cervical Neoplasms - diagnosis</subject><subject>Uterine Cervical Neoplasms - epidemiology</subject><issn>0091-7435</issn><issn>1096-0260</issn><issn>1096-0260</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU-LFDEQxYMo7rj6CQTJ0UuPSbqT7hYUZPw3sLAX9Rpqkspshu6kTboHFvzwZmfWRS-eUlR-9ap4j5CXnK054-rNYX07jWjXggleOkr26hFZcdarignFHpMVYz2v2qaWF-RZzgfGOFeseUou6kbwtuFyRX5txwnMTKOjm-sf248V72kM1GA6egMDNRBKTbNJiMGH_Vu6uYFhwLDHTCFYGqcppnkJfvalM0fqxynFY0FpwuwHj0XgRCa0SymtzxOkE_6cPHEwZHxx_16S758_fdt8ra6uv2w3H64qI4WcKwlooK-dbFsreFd3DWsNr1uFNQAD2whwisnecOZqpzjudi2AVM6JXmJr60vy_qw7LbvimMEwJxj0lPwI6VZH8Prfn-Bv9D4edScarrq-CLy-F0jx54J51qPPBocBAsYlayGbTjEu-q6g9Rk1Keac0D2s4Uzf5aYP-pSbvstNn3MrU6_-vvBh5k9QBXh3BrD4dPSYdDYna61PaGZto__vgt8LCK1F</recordid><startdate>20211001</startdate><enddate>20211001</enddate><creator>Wentzensen, Nicolas</creator><creator>Clarke, Megan A.</creator><creator>Perkins, Rebecca B.</creator><general>Elsevier Inc</general><general>Published by Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20211001</creationdate><title>Impact of COVID-19 on cervical cancer screening: Challenges and opportunities to improving resilience and reduce disparities</title><author>Wentzensen, Nicolas ; Clarke, Megan A. ; Perkins, Rebecca B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c525t-5aeca93f577d21838407c1376e3aa0ad42af6059c10f3f61ebb7aa56ff295e7d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Cervical cancer</topic><topic>Cervical precancer</topic><topic>COVID-19</topic><topic>Early Detection of Cancer</topic><topic>Female</topic><topic>Health disparities</topic><topic>HPV</topic><topic>Humans</topic><topic>Mass Screening</topic><topic>Pandemic</topic><topic>Pandemics</topic><topic>Papillomaviridae</topic><topic>Papillomavirus Infections - diagnosis</topic><topic>Papillomavirus Infections - epidemiology</topic><topic>SARS-CoV-2</topic><topic>Screening</topic><topic>Uterine Cervical Neoplasms - diagnosis</topic><topic>Uterine Cervical Neoplasms - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wentzensen, Nicolas</creatorcontrib><creatorcontrib>Clarke, Megan A.</creatorcontrib><creatorcontrib>Perkins, Rebecca B.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Preventive medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wentzensen, Nicolas</au><au>Clarke, Megan A.</au><au>Perkins, Rebecca B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of COVID-19 on cervical cancer screening: Challenges and opportunities to improving resilience and reduce disparities</atitle><jtitle>Preventive medicine</jtitle><addtitle>Prev Med</addtitle><date>2021-10-01</date><risdate>2021</risdate><volume>151</volume><spage>106596</spage><epage>106596</epage><pages>106596-106596</pages><artnum>106596</artnum><issn>0091-7435</issn><issn>1096-0260</issn><eissn>1096-0260</eissn><abstract>The COVID-19 pandemic has a major impact on a wide range of health outcomes. Disruptions of elective health services related to cervical screening, management of abnormal screening test results, and treatment of precancers, may lead to increases in cervical cancer incidence and exacerbate existing health disparities. Modeling studies suggest that a short delay of cervical screening in subjects with previously negative HPV results has minor effects on cancer outcomes, while delay of management and treatment can lead to larger increases in cervical cancer. Several approaches can mitigate the effects of disruption of cervical screening and management. HPV-based screening has higher accuracy compared to cytology, and a negative HPV result provides longer reassurance against cervical cancer; further, HPV testing can be conducted from self-collected specimens. Self-collection expands the reach of screening to underserved populations who currently do not participate in screening. Self-collection and can also provide alternative screening approaches during the pandemic because testing can be supported by telehealth and specimens collected in the home, substantially reducing patient-provider contact and risk of COVID-19 exposure, and also expanding the reach of catch-up services to address backlogs of screening tests that accumulated during the pandemic. Risk-based management allows prioritizing management of patients at highest risk of cervical cancer while extending screening intervals for those at lowest risk. The pandemic provides important lessons for how to make cervical screening more resilient to disruptions and how to reduce cervical cancer disparities that may be exacerbated due to disruptions of health services. •The pandemic increases disparities in cervical cancer prevention.•HPV self-sampling can extend the reach of cervical screening.•Screening and management visits should be prioritized by risk.•The pandemic provides an opportunity to make cervical screening more resilient.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>34217415</pmid><doi>10.1016/j.ypmed.2021.106596</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0091-7435
ispartof Preventive medicine, 2021-10, Vol.151, p.106596-106596, Article 106596
issn 0091-7435
1096-0260
1096-0260
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8241689
source MEDLINE; Elsevier ScienceDirect Journals
subjects Cervical cancer
Cervical precancer
COVID-19
Early Detection of Cancer
Female
Health disparities
HPV
Humans
Mass Screening
Pandemic
Pandemics
Papillomaviridae
Papillomavirus Infections - diagnosis
Papillomavirus Infections - epidemiology
SARS-CoV-2
Screening
Uterine Cervical Neoplasms - diagnosis
Uterine Cervical Neoplasms - epidemiology
title Impact of COVID-19 on cervical cancer screening: Challenges and opportunities to improving resilience and reduce disparities
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T00%3A15%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20COVID-19%20on%20cervical%20cancer%20screening:%20Challenges%20and%20opportunities%20to%20improving%20resilience%20and%20reduce%20disparities&rft.jtitle=Preventive%20medicine&rft.au=Wentzensen,%20Nicolas&rft.date=2021-10-01&rft.volume=151&rft.spage=106596&rft.epage=106596&rft.pages=106596-106596&rft.artnum=106596&rft.issn=0091-7435&rft.eissn=1096-0260&rft_id=info:doi/10.1016/j.ypmed.2021.106596&rft_dat=%3Cproquest_pubme%3E2548601298%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2548601298&rft_id=info:pmid/34217415&rft_els_id=S0091743521001808&rfr_iscdi=true